Viewpoint: Mass litigation targeting glyphosate could put beet farmers out of business

Sugar beet harvest in Idaho. Credit: American Sugar Alliance
Sugar beet harvest in Idaho. Credit: American Sugar Alliance

Glyphosate is used on 98% of Idaho’s sugar beet acres, allowing those farmers to contribute over $385 million to our state’s economy and support thousands of jobs. Without glyphosate, our sugar beet industry — America’s second largest — would likely be out of business.

Unfortunately, years of mass litigation is threatening the production and use of glyphosate in Idaho. To date, Bayer has settled tens of thousands of glyphosate lawsuits, paying over $11 billion — with more cases being filed every year. Bayer has informed glyphosate users that absent a manageable resolution to the mass litigation, we are at risk of losing the domestic production of glyphosate.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The safety of glyphosate has been extensively debated before EPA and European authorities for decades. EPA reaffirmed in 2020 that there are no risks of concern to human health when glyphosate is used in accordance with its current label, and that glyphosate is unlikely to be a human carcinogen.

European regulators reached similar findings in 2022, concluding that peer review of the risk assessment of glyphosate on the health of humans did not identify critical areas of concern, and that a hazard assessment of glyphosate found that it did not meet the scientific criteria to be classified as carcinogenic.

This legislative session, Idaho’s leaders should adopt legislation that reinforces the ability of Idaho’s agricultural businesses to rely on a pesticide’s label after it has undergone extensive and rigorous health and safety approval processes. Left unchecked, the glyphosate litigation will likely force Idaho farmers to rely on foreign sources for glyphosate.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
ChatGPT-Image-Jun-24-2026-11_36_47-AM
Why the human genome is less a script than a puzzle
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2026-06-25 at 10.55
Leading OB-GYN group challenges RFK, Jr. gutting of maternal vaccine schedule
Screenshot-2026-06-24-at-2.57.41-PM
Viewpoint: Trump’s Reflecting Pool algae fiasco points to a bigger culprit: Climate change
Screenshot-2026-06-24-at-2.40.46-PM
Hegseth reversal: As Air Force flu outbreak continues to surge, military reinstitutes mandatory vaccines for recruits
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
ChatGPT-Image-May-18-2026-12_06_18-PM-2
Defying death: The immortality movement goes mainstream

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.